Erste Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
CGH
CUAMC
S
Erste Asset Management's LKFT Position: Q2 2026 in Review
Erste Asset Management held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q2 2026 at 14,000 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #531.
Erste Asset Management first reported a position in LKFT in Q2 2019 and has held it in 21 quarters since. The position peaked at $1.76M in Q4 2019. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Erste Asset Management held 14,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $415K as of Q2 2026.
- Erste Asset Management left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q2 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #531 holding.
- Erste Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and has held it in 21 quarters since.
- Erste Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.76M in Q4 2019.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.